Simulated regional mean wetland seasons. by Nic Gedney (19762301)

Subjects:

Regional contemporary (1990–1999 mean) precipitation and JULES inundation fraction over the Amazon basin. by Nic Gedney (19762301)

Subjects:

Changes in decadal precipitation and JULES inundation between 1990–1999 and 2089–2098. by Nic Gedney (19762301)

Subjects:

Contemporary mean inundation fraction in the Amazon basin. by Nic Gedney (19762301)

Subjects:

All TPM values. by Hyuk Sung Yoon (20208672)

Data Sheet 1_Spatial and temporal variability in blue carbon accumulation in the largest salt marsh in British Columbia, Canada.docx by Karen E. Kohfeld (11936879)

Model diagnostics for all death events. by Xin Zhang (35492)

“…At the MMT of 23.5°C, the cumulative relative risk (cumRR) for mortality within a lag period of 0–14 days from the highest temperature (31°C) was estimated at 2.114 (95% confidence interval [CI]: 1.475 ~ 3.028). …”

Values for all quantifications. by Sravya Paluri (5475260)

Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

Subjects:

Water Withdrawal and Consumption Trends for Thermoelectric-Power Plants in the Conterminous United States, 2008–2020 by Kenneth D. Skinner (22280459)

Subjects:

Numeric values used to generate all the graphs presented in the figures. by Wenjia Yu (9422059)

Table1_Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease.docx by Jiahong Yi (14481735)

“…</p>Results<p>LTL was a negative factor for all-cause mortality (all p-value < 0.05). The risk of cardiovascular disease (CVD)-related death was decreased in Q3 (p < 0.001) and Q4 levels of LTL (p < 0.001) compared with the Q1 group. …”

Numerical values underlying all Figs. by Juliana Zimmermann (10507091)

The distribution of water footprint levels in China. a, 2005. b, 2010. c, 2015. d, 2022. by Jianqin Ma (20328414)

Subjects:

Innovation, nightlights and a continuous measure of city size. by Saul Estrin (8629173)

Subjects:

Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…This observational analysis aimed to explore the correlation between PNI levels and all-cause mortality (ACM) in patients undergoing prolonged glucocorticoid therapy for pneumonia.…”

Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…This observational analysis aimed to explore the correlation between PNI levels and all-cause mortality (ACM) in patients undergoing prolonged glucocorticoid therapy for pneumonia.…”

Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…This observational analysis aimed to explore the correlation between PNI levels and all-cause mortality (ACM) in patients undergoing prolonged glucocorticoid therapy for pneumonia.…”

Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…This observational analysis aimed to explore the correlation between PNI levels and all-cause mortality (ACM) in patients undergoing prolonged glucocorticoid therapy for pneumonia.…”

Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…This observational analysis aimed to explore the correlation between PNI levels and all-cause mortality (ACM) in patients undergoing prolonged glucocorticoid therapy for pneumonia.…”